Ovarian Cancer News and Research

RSS
Commonly known as the "silent killer," ovarian cancer leads to approximately 15,000 deaths each year in the United States, according to the American Cancer Society. Approximately 20,000 new cases are diagnosed each year, with the majority in patients diagnosed with late stage disease where the cancer has spread beyond the ovary. The prognosis is poor in these patients, leading to the high mortality from this disease. A diagnostic test is needed that can provide adequate predictive value to stratify patients with a pelvic mass into high risk of invasive ovarian cancer versus those with low risk, as well as a screening test for the diagnosis of early-stage ovarian cancer, which is essential for improving overall survival in patients. Ovarian cancer has up to a 90% cure rate following surgery and/or chemotherapy if detected in stage 1.
Cancer risk with birth control pills emerges again in latest study

Cancer risk with birth control pills emerges again in latest study

Study paves way for new therapeutic strategies to impede growth of virus-induced cancers

Study paves way for new therapeutic strategies to impede growth of virus-induced cancers

Immune-boosting drug combination may hold promise for treating ovarian cancer

Immune-boosting drug combination may hold promise for treating ovarian cancer

Findings reveal consistent racial disparities in ovarian, colon, and breast cancer patients’ survival

Findings reveal consistent racial disparities in ovarian, colon, and breast cancer patients’ survival

Researchers identify oral bacteria linked to esophageal cancer

Researchers identify oral bacteria linked to esophageal cancer

Oral bacteria that lead to periodontal disease linked to higher risk of esophageal cancer

Oral bacteria that lead to periodontal disease linked to higher risk of esophageal cancer

Researchers refine method to improve early detection of ovarian cancer

Researchers refine method to improve early detection of ovarian cancer

Researchers unlock genetic processes underlying cancer

Researchers unlock genetic processes underlying cancer

UT Southwestern researchers take early step toward personalized care for breast cancer

UT Southwestern researchers take early step toward personalized care for breast cancer

Study provides new insights into mechanisms contributing to ovarian cancer

Study provides new insights into mechanisms contributing to ovarian cancer

Abbreviated breast MRI may be valuable cancer detection tool for women with dense breasts

Abbreviated breast MRI may be valuable cancer detection tool for women with dense breasts

Study explores feasibility of mainstreaming genetic counseling for ovarian cancer

Study explores feasibility of mainstreaming genetic counseling for ovarian cancer

Study shows how naïve T-cells may affect tumor immunity and immunotherapy

Study shows how naïve T-cells may affect tumor immunity and immunotherapy

Researchers develop computer program to find new indications for old drugs

Researchers develop computer program to find new indications for old drugs

3D cultured spheroids could drive precision treatment for ovarian cancer

3D cultured spheroids could drive precision treatment for ovarian cancer

Study links dietary intake of isoflavones with elevated risk of advanced prostate cancer

Study links dietary intake of isoflavones with elevated risk of advanced prostate cancer

Women with history of infertility have increased risk of death, study shows

Women with history of infertility have increased risk of death, study shows

PARP inhibitors may have efficacy in selected TNBC patients outside of germline BRCA mutation

PARP inhibitors may have efficacy in selected TNBC patients outside of germline BRCA mutation

Non-invasive diagnostic tool developed for early detection of ovarian cancer

Non-invasive diagnostic tool developed for early detection of ovarian cancer

Researchers uncover surprising immune cell activity that may explain limitations of immunotherapy

Researchers uncover surprising immune cell activity that may explain limitations of immunotherapy